Westbourne Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-368
Closed -$213K 118
2025
Q4
$213K Buy
+368
New +$208K 0.06% 112
2024
Q4
Sell
-368
Closed -$228K 91
2024
Q3
$228K Sell
368
-200
-35% -$118K 0.08% 84
2024
Q2
$314K Hold
568
0.11% 75
2024
Q1
$330K Hold
568
0.12% 76
2023
Q4
$301K Hold
568
0.12% 76
2023
Q3
$288K Hold
568
0.13% 75
2023
Q2
$296K Buy
568
+20
+4% +$10.8K 0.13% 79
2023
Q1
$316K Buy
548
+20
+4% +$11.3K 0.15% 77
2022
Q4
$291K Buy
528
+20
+4% +$10.6K 0.15% 77
2022
Q3
$258K Buy
508
+15
+3% +$8.39K 0.14% 80
2022
Q2
$268K Hold
493
0.17% 70
2022
Q1
$291K Buy
493
+125
+34% +$71.8K 0.12% 80
2021
Q4
$246K Hold
368
0.1% 92
2021
Q3
$210K Sell
368
-365
-50% -$200K 0.1% 80
2021
Q2
$370K Sell
733
-30
-4% -$14.2K 0.17% 66
2021
Q1
$348K Hold
763
0.17% 66
2020
Q4
$355K Buy
763
+85
+13% +$39.9K 0.21% 62
2020
Q3
$299K Buy
+678
New +$280K 0.34% 39

Other funds holding TMO

Westbourne Investment Advisors's TMO Position: Q1 2026 in Review

Westbourne Investment Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 368 shares — an estimated $213K sold.

Westbourne Investment Advisors first reported a position in TMO in Q3 2020 and held it in 18 quarters. The position peaked at $370K in Q2 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Westbourne Investment Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Westbourne Investment Advisors sold 368 Thermo Fisher Scientific shares in Q1 2026, an estimated $213K.
  • Westbourne Investment Advisors first reported a position in Thermo Fisher Scientific in Q3 2020 and held it in 18 quarters.
  • Westbourne Investment Advisors's Thermo Fisher Scientific position peaked at $370K in Q2 2021.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Westbourne Investment Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.